ArticleLeukemia2024

Why are not all eligible chronic myeloid leukemia patients willing to attempt tyrosine kinase inhibitor discontinuation? A Czech nationwide analysis related to the TKI stopping trial HALF.

Daniela Žáčková et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.